Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on LinkedIn:
“A quick FDA Direct conversation today!
Biologic drugs are incredible, but they’re expensive – and they account for 51% of all drug spending.
How can we bring cheaper alternatives to market?”
Proceed to the video attached to the post.
More posts about FDA.